Westyn Branch-Elliman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibiotic Prophylaxis | 10 | 2020 | 640 | 3.970 |
Why?
|
Anti-Infective Agents | 8 | 2023 | 983 | 3.230 |
Why?
|
Surgical Wound Infection | 12 | 2021 | 1546 | 2.860 |
Why?
|
Pacemaker, Artificial | 5 | 2020 | 828 | 2.100 |
Why?
|
Infection Control | 10 | 2024 | 985 | 1.780 |
Why?
|
Clostridium Infections | 4 | 2019 | 562 | 1.540 |
Why?
|
Defibrillators, Implantable | 5 | 2022 | 1498 | 1.480 |
Why?
|
Anti-Bacterial Agents | 16 | 2023 | 7477 | 1.420 |
Why?
|
Prosthesis-Related Infections | 4 | 2020 | 497 | 1.370 |
Why?
|
Vancomycin | 6 | 2020 | 506 | 1.350 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1942 | 1.340 |
Why?
|
Staphylococcal Infections | 7 | 2020 | 1398 | 1.280 |
Why?
|
Pandemics | 15 | 2024 | 8748 | 1.230 |
Why?
|
Ambulatory Surgical Procedures | 4 | 2019 | 452 | 1.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2020 | 704 | 1.100 |
Why?
|
Veterans | 9 | 2023 | 2669 | 1.040 |
Why?
|
Veterans Health | 6 | 2024 | 216 | 1.030 |
Why?
|
Cross Infection | 6 | 2023 | 1426 | 0.940 |
Why?
|
Informed Consent | 2 | 2021 | 1010 | 0.930 |
Why?
|
Data Collection | 3 | 2024 | 3327 | 0.920 |
Why?
|
Communicable Diseases | 3 | 2023 | 874 | 0.900 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 275 | 0.860 |
Why?
|
Virus Diseases | 2 | 2022 | 724 | 0.830 |
Why?
|
Hypersensitivity | 2 | 2023 | 1172 | 0.820 |
Why?
|
Mastitis | 2 | 2013 | 42 | 0.820 |
Why?
|
Urinary Tract Infections | 2 | 2020 | 804 | 0.760 |
Why?
|
Electronic Health Records | 7 | 2023 | 4887 | 0.760 |
Why?
|
Antiviral Agents | 6 | 2024 | 3073 | 0.760 |
Why?
|
Therapeutic Human Experimentation | 1 | 2021 | 43 | 0.760 |
Why?
|
Natural Language Processing | 2 | 2023 | 1203 | 0.720 |
Why?
|
Pyuria | 1 | 2020 | 30 | 0.710 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2015 | 278 | 0.710 |
Why?
|
Hospitals, Veterans | 8 | 2022 | 395 | 0.700 |
Why?
|
Norovirus | 1 | 2020 | 37 | 0.680 |
Why?
|
Quarantine | 1 | 2022 | 186 | 0.670 |
Why?
|
Guideline Adherence | 3 | 2019 | 2235 | 0.650 |
Why?
|
Civil Defense | 1 | 2021 | 115 | 0.640 |
Why?
|
United States Department of Veterans Affairs | 7 | 2023 | 937 | 0.640 |
Why?
|
Bacterial Infections | 2 | 2017 | 1397 | 0.630 |
Why?
|
Patient Identification Systems | 1 | 2019 | 75 | 0.630 |
Why?
|
Abscess | 2 | 2013 | 606 | 0.630 |
Why?
|
Gastroenteritis | 1 | 2020 | 235 | 0.590 |
Why?
|
Catheters, Indwelling | 2 | 2017 | 436 | 0.590 |
Why?
|
Algorithms | 7 | 2021 | 14164 | 0.590 |
Why?
|
Population Surveillance | 2 | 2020 | 2596 | 0.560 |
Why?
|
Humans | 98 | 2024 | 768166 | 0.550 |
Why?
|
Sterilization | 1 | 2017 | 132 | 0.530 |
Why?
|
beta-Lactams | 1 | 2017 | 158 | 0.500 |
Why?
|
Documentation | 2 | 2020 | 917 | 0.500 |
Why?
|
Retrospective Studies | 31 | 2023 | 81762 | 0.500 |
Why?
|
Quality Assurance, Health Care | 2 | 2023 | 2176 | 0.500 |
Why?
|
Data Mining | 1 | 2020 | 563 | 0.490 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 192 | 0.490 |
Why?
|
Staphylococcus aureus | 3 | 2019 | 1430 | 0.490 |
Why?
|
Outpatients | 3 | 2023 | 1600 | 0.490 |
Why?
|
Disease Outbreaks | 5 | 2024 | 1761 | 0.480 |
Why?
|
Neutropenia | 1 | 2019 | 892 | 0.460 |
Why?
|
Bacteremia | 1 | 2021 | 986 | 0.460 |
Why?
|
Intensive Care Units | 4 | 2018 | 3800 | 0.460 |
Why?
|
Immunocompromised Host | 1 | 2019 | 863 | 0.460 |
Why?
|
Ligation | 1 | 2015 | 446 | 0.460 |
Why?
|
Drug Hypersensitivity | 1 | 2023 | 923 | 0.450 |
Why?
|
Housekeeping, Hospital | 1 | 2014 | 17 | 0.450 |
Why?
|
Office Visits | 1 | 2018 | 595 | 0.450 |
Why?
|
Environmental Microbiology | 1 | 2014 | 47 | 0.450 |
Why?
|
Patients' Rooms | 1 | 2014 | 63 | 0.440 |
Why?
|
Computer Systems | 1 | 2015 | 469 | 0.440 |
Why?
|
Education, Professional | 1 | 2014 | 53 | 0.440 |
Why?
|
Anti-Inflammatory Agents | 2 | 2023 | 1805 | 0.430 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5536 | 0.420 |
Why?
|
Schools | 4 | 2022 | 1498 | 0.420 |
Why?
|
Esophageal and Gastric Varices | 1 | 2015 | 215 | 0.410 |
Why?
|
Hospital Costs | 2 | 2017 | 957 | 0.410 |
Why?
|
Hysterectomy | 1 | 2018 | 863 | 0.410 |
Why?
|
Luminescent Measurements | 1 | 2014 | 342 | 0.400 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2015 | 249 | 0.390 |
Why?
|
Influenza Vaccines | 1 | 2019 | 781 | 0.390 |
Why?
|
Disinfection | 1 | 2014 | 207 | 0.390 |
Why?
|
United States | 25 | 2024 | 73039 | 0.370 |
Why?
|
Drug Contamination | 1 | 2012 | 151 | 0.360 |
Why?
|
Patient Admission | 1 | 2018 | 1365 | 0.360 |
Why?
|
Vaccination | 6 | 2023 | 3437 | 0.350 |
Why?
|
Program Development | 1 | 2017 | 1300 | 0.350 |
Why?
|
Disease Transmission, Infectious | 1 | 2015 | 560 | 0.340 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 350 | 0.330 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1932 | 0.330 |
Why?
|
Postpartum Period | 2 | 2013 | 1198 | 0.320 |
Why?
|
Aged | 26 | 2024 | 171504 | 0.320 |
Why?
|
Secondary Prevention | 1 | 2015 | 1474 | 0.310 |
Why?
|
Feedback | 2 | 2023 | 799 | 0.310 |
Why?
|
Influenza, Human | 1 | 2019 | 1541 | 0.300 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 1126 | 0.290 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 2004 | 0.290 |
Why?
|
Cohort Studies | 11 | 2023 | 41754 | 0.280 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2298 | 0.280 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 1014 | 0.280 |
Why?
|
Workload | 1 | 2013 | 849 | 0.280 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2726 | 0.280 |
Why?
|
Dexamethasone | 3 | 2023 | 1965 | 0.270 |
Why?
|
Harm Reduction | 2 | 2023 | 143 | 0.240 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.240 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 591 | 0.240 |
Why?
|
Quality Improvement | 6 | 2023 | 3857 | 0.240 |
Why?
|
Endoscopy | 1 | 2015 | 1854 | 0.240 |
Why?
|
Research Design | 1 | 2021 | 6211 | 0.240 |
Why?
|
Male | 30 | 2024 | 364719 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3626 | 0.220 |
Why?
|
Middle Aged | 23 | 2023 | 223492 | 0.220 |
Why?
|
Female | 29 | 2024 | 397192 | 0.200 |
Why?
|
Aged, 80 and over | 11 | 2022 | 59629 | 0.200 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5367 | 0.200 |
Why?
|
Health Personnel | 3 | 2024 | 3385 | 0.200 |
Why?
|
Drug Users | 1 | 2023 | 134 | 0.200 |
Why?
|
Radiology, Interventional | 2 | 2023 | 483 | 0.200 |
Why?
|
Sisomicin | 1 | 2021 | 5 | 0.200 |
Why?
|
Hepatitis C | 1 | 2012 | 1595 | 0.190 |
Why?
|
Klebsiella | 1 | 2021 | 49 | 0.190 |
Why?
|
Incidence | 4 | 2022 | 21538 | 0.180 |
Why?
|
Mass Vaccination | 1 | 2022 | 111 | 0.180 |
Why?
|
Caliciviridae Infections | 1 | 2020 | 29 | 0.170 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2784 | 0.170 |
Why?
|
Risk Factors | 10 | 2022 | 74944 | 0.170 |
Why?
|
Paraproteinemias | 1 | 2022 | 252 | 0.170 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2023 | 291 | 0.170 |
Why?
|
Policy | 1 | 2023 | 513 | 0.160 |
Why?
|
Cefazolin | 1 | 2019 | 95 | 0.160 |
Why?
|
Communicable Diseases, Emerging | 2 | 2024 | 149 | 0.160 |
Why?
|
Inappropriate Prescribing | 1 | 2022 | 212 | 0.160 |
Why?
|
Oseltamivir | 1 | 2019 | 76 | 0.160 |
Why?
|
Public Policy | 1 | 2023 | 552 | 0.160 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 282 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.160 |
Why?
|
Substance Abuse, Intravenous | 1 | 2023 | 530 | 0.160 |
Why?
|
Hospitalization | 4 | 2022 | 10840 | 0.160 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7951 | 0.150 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.150 |
Why?
|
Soaps | 1 | 2018 | 30 | 0.150 |
Why?
|
Death | 1 | 2023 | 683 | 0.150 |
Why?
|
Urinalysis | 1 | 2020 | 370 | 0.150 |
Why?
|
Treatment Outcome | 8 | 2023 | 65371 | 0.150 |
Why?
|
Daptomycin | 1 | 2018 | 71 | 0.150 |
Why?
|
Goals | 1 | 2023 | 717 | 0.140 |
Why?
|
Arthritis | 1 | 2023 | 684 | 0.140 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 162 | 0.140 |
Why?
|
RNA, Viral | 2 | 2022 | 2872 | 0.140 |
Why?
|
Boston | 4 | 2020 | 9374 | 0.140 |
Why?
|
Arthroplasty | 1 | 2019 | 308 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 716 | 0.140 |
Why?
|
Health Policy | 3 | 2024 | 2698 | 0.140 |
Why?
|
Substance-Related Disorders | 2 | 2023 | 4423 | 0.140 |
Why?
|
Electrophysiology | 1 | 2019 | 1266 | 0.140 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2019 | 342 | 0.140 |
Why?
|
Adult | 14 | 2024 | 223646 | 0.130 |
Why?
|
Benchmarking | 1 | 2023 | 1057 | 0.130 |
Why?
|
Critical Pathways | 1 | 2020 | 476 | 0.130 |
Why?
|
Microbiological Techniques | 1 | 2017 | 97 | 0.130 |
Why?
|
Candida | 1 | 2017 | 173 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1143 | 0.130 |
Why?
|
Psoriasis | 1 | 2023 | 926 | 0.130 |
Why?
|
Equipment Contamination | 1 | 2017 | 183 | 0.120 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15662 | 0.120 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 623 | 0.120 |
Why?
|
Probability | 1 | 2020 | 2479 | 0.120 |
Why?
|
Surgical Instruments | 1 | 2017 | 381 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 367 | 0.110 |
Why?
|
Hospitals | 3 | 2023 | 3886 | 0.110 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2017 | 511 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2024 | 22291 | 0.110 |
Why?
|
Carrier State | 1 | 2017 | 529 | 0.110 |
Why?
|
Oxygen | 2 | 2022 | 4270 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1826 | 0.110 |
Why?
|
Decision Trees | 1 | 2015 | 508 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2011 | 0.110 |
Why?
|
Motivation | 1 | 2023 | 2020 | 0.100 |
Why?
|
Diarrhea | 1 | 2019 | 1320 | 0.100 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 292 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1907 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1189 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3968 | 0.100 |
Why?
|
Qualitative Research | 1 | 2023 | 3140 | 0.100 |
Why?
|
Markov Chains | 1 | 2015 | 979 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3216 | 0.090 |
Why?
|
Students | 1 | 2021 | 1744 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 789 | 0.090 |
Why?
|
Device Removal | 1 | 2016 | 643 | 0.090 |
Why?
|
Models, Economic | 1 | 2015 | 719 | 0.090 |
Why?
|
Quality Control | 1 | 2014 | 836 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1279 | 0.090 |
Why?
|
Drug Combinations | 1 | 2017 | 2089 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12077 | 0.090 |
Why?
|
Operating Rooms | 1 | 2017 | 790 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1668 | 0.090 |
Why?
|
Triage | 1 | 2017 | 997 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 2496 | 0.090 |
Why?
|
Loneliness | 2 | 2022 | 211 | 0.080 |
Why?
|
New York City | 1 | 2012 | 737 | 0.080 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.080 |
Why?
|
Plasma Cells | 2 | 2023 | 599 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2763 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1443 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2442 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2665 | 0.080 |
Why?
|
Occupational Health | 1 | 2015 | 812 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2923 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 755 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1765 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3781 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2709 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13290 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2015 | 1359 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3706 | 0.070 |
Why?
|
Pilot Projects | 2 | 2023 | 8741 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2507 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 12800 | 0.070 |
Why?
|
Ambulatory Care Facilities | 1 | 2012 | 939 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 40218 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2013 | 2434 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 13053 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13490 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6526 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 565 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12543 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1951 | 0.050 |
Why?
|
Databases, Factual | 1 | 2019 | 8080 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8542 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54926 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2018 | 15832 | 0.050 |
Why?
|
Breast | 1 | 2011 | 1976 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3837 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8509 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9669 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14729 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5717 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6498 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15454 | 0.050 |
Why?
|
Mass Screening | 2 | 2019 | 5458 | 0.050 |
Why?
|
Pregnancy | 2 | 2013 | 30256 | 0.040 |
Why?
|
Naltrexone | 1 | 2023 | 319 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2015 | 4543 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3239 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 60066 | 0.040 |
Why?
|
Vascular Patency | 1 | 2023 | 917 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2023 | 538 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2019 | 198 | 0.040 |
Why?
|
Disaster Planning | 1 | 2024 | 560 | 0.040 |
Why?
|
Infusions, Parenteral | 1 | 2018 | 396 | 0.040 |
Why?
|
Anxiety | 2 | 2022 | 4672 | 0.040 |
Why?
|
Child | 2 | 2022 | 80917 | 0.030 |
Why?
|
Clinical Competence | 1 | 2013 | 4858 | 0.030 |
Why?
|
Radiography, Interventional | 1 | 2023 | 1131 | 0.030 |
Why?
|
Adolescent | 3 | 2021 | 89169 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1557 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26379 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2023 | 2741 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1088 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 951 | 0.030 |
Why?
|
Hepacivirus | 1 | 2002 | 1344 | 0.030 |
Why?
|
Teaching | 1 | 2021 | 1171 | 0.030 |
Why?
|
Geriatrics | 1 | 2018 | 394 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2023 | 1791 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22371 | 0.030 |
Why?
|
Depression | 2 | 2022 | 8230 | 0.030 |
Why?
|
Educational Measurement | 1 | 2018 | 1260 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 26422 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2566 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3905 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9613 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1444 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12465 | 0.020 |
Why?
|
Nose | 1 | 2012 | 522 | 0.020 |
Why?
|
Software | 1 | 2002 | 4478 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3643 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4530 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15869 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3782 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6082 | 0.010 |
Why?
|
Reading Frames | 1 | 2002 | 16 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 2002 | 158 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2002 | 363 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 30010 | 0.010 |
Why?
|
Viral Nonstructural Proteins | 1 | 2002 | 228 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2002 | 930 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42669 | 0.010 |
Why?
|
Genome, Viral | 1 | 2002 | 674 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2002 | 2179 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 30238 | 0.010 |
Why?
|
Point Mutation | 1 | 2002 | 1596 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3772 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13421 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3568 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17622 | 0.010 |
Why?
|
Genotype | 1 | 2002 | 13045 | 0.000 |
Why?
|